Glaxo (GSK) rejects a $68 billion buyout offer for its consumer healthcare unit from Unilever. FDA updates for Pfizer (PFE), AbbVie (ABBV) and AstraZeneca (AZN) grab headlines.
AbbVie, The Andersons and Ingredion are highlighted in this Zacks Value Traders article.
Not all stocks are selling off to start 2022. These cheap, top Zacks Ranked stocks are doing the opposite.